PMID: 7538548May 1, 1995Paper

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group

The Journal of Infectious Diseases
A J JapourD R Kuritzkes

Abstract

Zidovudine resistance mutations at reverse transcriptase codons 215 or 41 were found in two-thirds of human immunodeficiency virus type 1 (HIV-1) isolates obtained at baseline from patients enrolled in an AIDS Clinical Trials Group (ACTG) protocol that compared didanosine with continued zidovudine in patients with > or = 16 weeks of previous zidovudine therapy (ACTG 116B/117). The combined presence of mutations at both codons 215 and 41 conferred an increased risk for progression (relative hazard, 1.82; 95% confidence interval [CI], 1.02-3.26) and an increased risk for death (RH, 5.42; 95% CI, 1.92-15.30) in analyses that controlled for other factors predictive of progression. However, the benefit of switching to didanosine compared with continued zidovudine therapy was independent of the presence of these mutations. Although this information is not helpful in determining when to alter therapy, detection of zidovudine resistance mutations provides prognostic information in patients with advanced HIV disease.

Citations

Sep 13, 2002·Journal of Medical Virology·Jane MullenPhilippa Easterbrook
Nov 14, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K Leriche-GuérinC Trépo
Apr 1, 1995·Antiviral Research·D W KimberlinR J Whitley
May 1, 1995·Clinical and Diagnostic Virology·R T D'Aquila
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Y SitnitskayaW Borkowsky
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott A WegnerUNKNOWN RV-125 Centers for Education and Research on Therapeutics Study Team
Mar 12, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·D ReyD A Katzenstein
Nov 6, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·P OrlandiP Rossi
Jun 1, 1997·Acta Paediatrica. Supplement·K McIntosh
Apr 5, 2002·Clinical Microbiology Reviews·Robert W Shafer
Apr 19, 2003·Journal of Clinical Microbiology·Daniel R KuritzkesDean L Winslow
Sep 9, 2006·Annual Review of Medicine·Athe M N Tsibris, Daniel R Kuritzkes
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·D R Kuritzkes
May 19, 1997·The American Journal of Medicine·D L Mayers
Jan 1, 1997·The Journal of the Association of Nurses in AIDS Care : JANAC·R C MacIntyreM Philippek
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·M A Wainberg, D W Cameron
May 24, 1997·Lancet·S G Deeks, D I Abrams
Feb 1, 1997·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Philippe SudreUNKNOWN The Swiss HIV Cohort Study
Nov 7, 2014·PLoS Computational Biology·Sathej GopalakrishnanWilhelm Huisinga
Apr 29, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R J Pires NetoB A L Fonseca
Apr 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Daniel R KuritzkesUNKNOWN Adult ACTG Protocol 306 370 Teams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.